BMJ  2006;333 (9 September), doi:10.1136/bmj.333.7567.0

Routine use of ibuprofen after hip replacement is not justified

Routine postoperative ibuprofen as prophylaxis for ectopic bone formation after hip replacement surgery has no significant clinical benefits 6 to 12 months after surgery. Fransen and colleagues (p 519) randomised 902 patients undergoing elective primary or revision total hip replacement surgery to 14 days' treatment with ibuprofen (1200 mg daily) or matching placebo started within 24 hours of surgery. Despite a decreased risk of ectopic bone formation, ibuprofen made no significant difference to improvements in hip pain or physical function. It did, however, increase the risk of major bleeding complications.


Figure 1
Credit: THE GEORGE INST/U OF SYDNEY

 


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Evidence based diagnosis: We may need to be open to new ideas
Huw Llewelyn
BMJ 2006 333: 549. [Extract] [Full Text] [PDF]

Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial
Marlene Fransen, Craig Anderson, Jan Douglas, Stephen MacMahon, Bruce Neal, Robyn Norton, Mark Woodward, Ian D Cameron, Ross Crawford, Sing Kai Lo, Garnet Tregonning, Margaret Windolf HIPAID Collaborative Group
BMJ 2006 333: 519. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ